Cagrilintide Molecule Peptides Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial The Lancet CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide 5mg Loti Labs Cagrilintide: What It Is and How It's Being Studied for Weight Loss Cagrilintide Peptide Research Explained Long Acting Amylin Analogue & Metabolic Co Agonist